{"title":"A Burning Issue on Oral Mucosal Diseases: Case Series with Review","authors":"Durba Roychowdhury, Rudra Prasad Chatterjee, S. Mahmud, Sudeshna Bagchi, Arunit Chatterjee","doi":"10.9734/jammr/2024/v36i85528","DOIUrl":"https://doi.org/10.9734/jammr/2024/v36i85528","url":null,"abstract":"Oral Lichenoid Reaction (OLR) is a chronic inflammatory lesion of the oral mucosa that occurs as an allergic response to certain dental materials, medications and systemic diseases. The frequency of OLR in the general population has been documented to be very less. The clinical and histological features of OLR closely resemble those of Oral Lichen Planus (OLP), making it challenging to distinguish between the two clinically. OLRs might have a higher malignant potential than OLP. The diagnosis and treatment of OLR is very crucial as misdiagnosis may result in detrimental effects on the biophysical health of the patient. Here, we present case series of two patients who presented with amalgam restorations and burning sensation on the buccal mucosa while consumption of hot and spicy food. An immunohistopathological evaluation confirmed the diagnosis as Oral Lichenoid Reaction. Elimination of causative factors remain the mainstay of treatment which markedly reduces the sufferings of the patient with a commendable result.","PeriodicalId":506708,"journal":{"name":"Journal of Advances in Medicine and Medical Research","volume":"65 20","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-07-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141798443","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Shazain Khan, Raheel Chaudhry, Arhum Mahmood, M. Masmoum, Shaf A. Altaf, M. S. S. Mirza
{"title":"Myocardial Infarction: Causes, Symptoms, and Emergency Response","authors":"Shazain Khan, Raheel Chaudhry, Arhum Mahmood, M. Masmoum, Shaf A. Altaf, M. S. S. Mirza","doi":"10.9734/jammr/2024/v36i85527","DOIUrl":"https://doi.org/10.9734/jammr/2024/v36i85527","url":null,"abstract":"Myocardial infarction (MI), often known as a heart attack, is a severe form of coronary artery disease that causes myocardial damage or necrosis as a result of persistent ischemia. Hypertension, atherosclerosis, diabetes, hyperlipidemia, smoking, lack of physical activity, and obesity are all significant risk factors. Recognizing symptoms such as chest pain, shortness of breath, heavy perspiration, and nausea is crucial for timely treatment. Advances in high-sensitivity troponin tests, coronary angiography, percutaneous coronary intervention (PCI), and pharmaceutical therapies, such as antiplatelet medications, beta-blockers, and statins, have all improved patient outcomes. The reduction of MI morbidity and mortality is contingent on early detection, prompt intervention, and ongoing care. This comprehensive study underlines the need to identify MI symptoms early and call emergency medical services to improve patient outcomes. Emerging medicines and future tactics in MI therapy, including novel antiplatelet agents and precision medicine approaches, hold promise for enhancing patient care.","PeriodicalId":506708,"journal":{"name":"Journal of Advances in Medicine and Medical Research","volume":"58 15","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-07-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141799346","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
I. Folorunsho, N. M. Harry, Chukwubueze Obiajunwa, Oluwatosin Arubuolawe, A. K. Busari, Chidalu N Ibeneme, Gibson Anugwom
{"title":"PTSD Treatment: An Inquiry into the Promising Potential of Psilocybin","authors":"I. Folorunsho, N. M. Harry, Chukwubueze Obiajunwa, Oluwatosin Arubuolawe, A. K. Busari, Chidalu N Ibeneme, Gibson Anugwom","doi":"10.9734/jammr/2024/v36i85525","DOIUrl":"https://doi.org/10.9734/jammr/2024/v36i85525","url":null,"abstract":"Post-Traumatic Stress Disorder (PTSD) is a debilitating mental health condition that can occur after experiencing or witnessing a traumatic event. The impact of PTSD extends beyond the individual, affecting families, communities, and society as a whole. This study aims to investigate the potential of psilocybin as a treatment for PTSD. Psilocybin, after being metabolized to psilocin, binds to various serotonergic receptors to exert some major effects such as a reduction in negative mood and an increase in optimism, enhanced ability for introspection and perceptual changes, a reduction in amygdala reactivity during emotion processing, and—as has been found in animal studies—an extinction of the fear response and increased hippocampal neurogenesis. However, psychedelics such as psilocybin may lead to brief episodes of nausea, vomiting, and physical discomfort. This study indicated that there is an urgent need for innovative therapies that could enhance the effectiveness of PTSD treatments. As this review highlights, psilocybin and some other psychedelics offer prospects for an additional method of treating PTSD. They have the potential to directly address PTSD symptoms and can also be used as an adjunct to psychotherapy.","PeriodicalId":506708,"journal":{"name":"Journal of Advances in Medicine and Medical Research","volume":"42 10","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-07-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141809742","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Shaheen Sultana, Kayode Aguda, Adetola G Mowo-wale, Regina Azipu, Chiedozie Steven Nzotta, S. Alzaki, Marian Obi, Onyinye Ezewudo, Abdelhay Hassan Taha Mohamed, Shwetha Gopal, Tope Mwuese Anyiman, N. G. Obiefuna, Efi Uyoyou Winners, Omolola Okunromade, Prince Agbakahi, Jovita Echere
{"title":"Efficacy of Smartphone Applications in Hypertension Management: A Systematic Review","authors":"Shaheen Sultana, Kayode Aguda, Adetola G Mowo-wale, Regina Azipu, Chiedozie Steven Nzotta, S. Alzaki, Marian Obi, Onyinye Ezewudo, Abdelhay Hassan Taha Mohamed, Shwetha Gopal, Tope Mwuese Anyiman, N. G. Obiefuna, Efi Uyoyou Winners, Omolola Okunromade, Prince Agbakahi, Jovita Echere","doi":"10.9734/jammr/2024/v36i85522","DOIUrl":"https://doi.org/10.9734/jammr/2024/v36i85522","url":null,"abstract":"Background: Hypertension is a global health challenge, affecting over a billion individuals worldwide. Despite the availability of effective treatments, control rates remain suboptimal. Emerging technologies, such as smartphone applications, offer new avenues to enhance hypertension management. This systematic review aims to evaluate the effectiveness of smartphone applications in hypertension management. \u0000Methods: To provide a comprehensive overview of the current evidence, we systematically searched PubMed, EMBASE, and the Cochrane Library for both randomized controlled trials (RCTs) and non-randomized clinical trials that examined the use of smartphone applications in hypertension management. Our search included all relevant studies published until June 2023. Studies were selected based on predefined criteria relating to study design, patient population, intervention type, and outcome measures. Data were extracted and analyzed by two independent reviewers. The primary outcome of interest was blood pressure control, while secondary outcomes included medication adherence and health-related knowledge. \u0000Results: From our systematic search, a total of 11 RCTs involving 1,685 participants met our inclusion criteria and were included in the review. The smartphone-based interventions varied widely across studies, ranging from simple text reminders to comprehensive digital therapeutics systems, and including education-based applications, self-monitoring programs, and telemonitoring systems. Collectively, these interventions demonstrated significant improvements in blood pressure control in the intervention groups compared to the standard care. Additionally, they showed increased medication adherence and enhanced health-related knowledge, suggesting potential benefits beyond blood pressure control. \u0000Conclusion: The reviewed studies suggest that smartphone applications may provide a beneficial tool for managing hypertension. They show improvements in blood pressure control, medication adherence, and health-related knowledge. These findings underline the potential of digital health interventions to address a global health concern. Nevertheless, further robust, well-designed RCTs are needed to corroborate these findings and explore the long-term effectiveness, sustainability, and cost-effectiveness of smartphone applications in hypertension management. With the rapid advancement in technology, the role of digital health in hypertension management is likely to become even more critical and complex, making this an area of crucial importance for future research.","PeriodicalId":506708,"journal":{"name":"Journal of Advances in Medicine and Medical Research","volume":"55 3","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-07-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141813305","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
A. Norberg, Paulo Roberto Blanco Moreira Norberg, Fernanda Castro Manhães, B. M. Mangiavacchi, Ligia Cordeiro Matos Faial, Ivy de Campos, Renato Mataveli Ferreira Filho, Alcemar Antônio Lopes de Matos, Kelen Salaroli Viana, Júlio Cesar dos Santos Boechat, Juliana Toledo Campos Arêas
{"title":"A Systematic Review on Prototheca spp. Infections in the Human Central Nervous System and Evaluation of Therapeutic Drug Approaches","authors":"A. Norberg, Paulo Roberto Blanco Moreira Norberg, Fernanda Castro Manhães, B. M. Mangiavacchi, Ligia Cordeiro Matos Faial, Ivy de Campos, Renato Mataveli Ferreira Filho, Alcemar Antônio Lopes de Matos, Kelen Salaroli Viana, Júlio Cesar dos Santos Boechat, Juliana Toledo Campos Arêas","doi":"10.9734/jammr/2024/v36i85523","DOIUrl":"https://doi.org/10.9734/jammr/2024/v36i85523","url":null,"abstract":"Background and Aim: Prototheca is a genus of unicellular, non-photosynthetic microalgae found in diverse environments, including water, soil, and the intestinal microbiota of animals and humans. They are the only algae pathogenic to humans. Infections of the Central Nervous System (CNS) by Prototheca spp. are rare but severe. This research aims to systematically review the pathogenic potential of Prototheca spp. as CNS infectious agents in humans, identify underlying conditions that contribute to disease development, and evaluate the most suitable drug therapy alternatives for this clinical condition. \u0000Methods: A systematic review was conducted using PubMed, SciELO, and Google Scholar databases. Search terms included \"Prototheca,\" \"Central Nervous System,\" \"meningitis,\" \"encephalitis,\" \"meningoencephalitis,\" and \"brain.\" Manuscripts published in English, Portuguese, Spanish, and Russian from 1981 to 2024 were reviewed. \u0000Results: The review identified 15 case reports of CNS infections by Prototheca spp. described in 14 scientific articles. Three species were implicated: Prototheca wickerhamii, Prototheca zopfii, and Prototheca trispora, with Prototheca wickerhamii being the most prevalent (66.6%). Only four patients were immunocompromised. A significant association was found between hydrocephalus in children and vulnerability to CNS protothecosis, accounting for 20% of cases. All fatal cases occurred in immunocompromised patients. Resistance profile analysis showed 88.9% susceptibility to amphotericin B and susceptibility to two triazoles (voriconazole and isavuconazole) that cross the blood-brain barrier. \u0000Conclusion: Immunodeficiency is not a prerequisite for susceptibility to CNS infections by Prototheca spp., but it predicts an unfavorable prognosis. The most promising treatments are combinations of amphotericin B with tetracyclines or isavuconazole. Dosage adjustments are necessary due to the toxicity of long-term algicidal antifungal treatments, posing a challenge in managing drug therapy.","PeriodicalId":506708,"journal":{"name":"Journal of Advances in Medicine and Medical Research","volume":"132 29","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-07-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141811622","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Letícia Neves Mode, Cindy Mozer Nakamura, T. Cunha, Fernanda Cardoso Nakamoto, M. Leonardis, Cid André Fidelis de Paula Gomes, F. Politti, D. Biasotto-Gonzalez
{"title":"Protocol for a Randomized Clinical Trial of Oculomotor Exercises Added to Treatment for Temporomandibular Disorders","authors":"Letícia Neves Mode, Cindy Mozer Nakamura, T. Cunha, Fernanda Cardoso Nakamoto, M. Leonardis, Cid André Fidelis de Paula Gomes, F. Politti, D. Biasotto-Gonzalez","doi":"10.9734/jammr/2024/v36i75518","DOIUrl":"https://doi.org/10.9734/jammr/2024/v36i75518","url":null,"abstract":"Objective: To evaluate the effect of adding oculomotor exercises to the treatment of Temporomandibular Disorder (TMD) on pain intensity, range of mandibular movement, TMD severity, and ocular convergence insufficiency (CI), immediately, 3 months, and 6 months after treatment. \u0000Study Design: Controlled and randomized clinical trial included blinded evaluators and participants. \u0000Methodology: Individuals aged 18–45 years diagnosed with TMD and convergence insufficiency. \u0000Intervention: Two groups: the experimental group (EG) and the control group (CG) groups will receive 12 treatment sessions. Main outcome measures: pain intensity, range of mandibular movement, convergence insufficiency, and severity of TMD during follow-up immediately after treatment, 3 and 6 months. \u0000Analysis: The statistical analysis will use linear mixed models based on the intention to treat. The significance level will be set at 5%. \u0000Results: This is a preliminary protocol; results will be available once the study is completed. It is expected relevant patient clinical improvement results. \u0000Conclusion: It will be possible to determine the effects of adding oculomotor exercises in the treatment of TMD. \u0000Implications for Practice: If successful, the protocol could be integrated into clinical practice as an adjunct to conventional therapy for TMD, expanding the therapeutic options available to healthcare professionals and patients.","PeriodicalId":506708,"journal":{"name":"Journal of Advances in Medicine and Medical Research","volume":"9 26","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-07-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141640518","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Chiegboka S. Frances, Usoro U.T Edidiongobong, Odion E. Hendrix, Enotiemonria J. Ighodalo, Etukokwu Ijeoma U., Awolo O. Daniel, Akeredolu W. Utome, Abebe E. Stephen, Oshadiya O. Christian, Osamuyi Emmanuella I., Ezedigwe O. Collins, Osigbeme Azemobor, Akhaine J. Precious
{"title":"Effects of Comorbidities on Lassa Fever: A 5-Year Retrospective Analysis of Cases Admitted in a Lassa Fever Research Institute in Nigeria (2019-2023)","authors":"Chiegboka S. Frances, Usoro U.T Edidiongobong, Odion E. Hendrix, Enotiemonria J. Ighodalo, Etukokwu Ijeoma U., Awolo O. Daniel, Akeredolu W. Utome, Abebe E. Stephen, Oshadiya O. Christian, Osamuyi Emmanuella I., Ezedigwe O. Collins, Osigbeme Azemobor, Akhaine J. Precious","doi":"10.9734/jammr/2024/v36i75516","DOIUrl":"https://doi.org/10.9734/jammr/2024/v36i75516","url":null,"abstract":"Background: Co-morbidities in Lassa fever refers to the presence of other underlying medical conditions or diseases in individuals infected with the virus. These co-morbidities can significantly affect the progression and outcome of Lassa fever, making it a complex and challenging infectious disease to control. \u0000Objective: To determine the effects of Co-morbidities on Lassa fever and it's management between 2019-2023 in a Lassa Fever Research Institute in Nigeria. \u0000Methodology: This study was conducted at the Lassa Fever Research Institute at Irrua Specialist Teaching Hospital (ISTH) in Edo State, Nigeria. It engaged a retrospective cross-sectional design and employed a systematic sampling technique. Data analysis was done using IBM SPSS version 21.0 software for descriptive statistics. Associations were tested using the Chi-square test, with a significance level set at p<0.05. \u0000Results: The study found that Lassa fever had no specificity for age as it affected individuals across a wide age range (18-78 years), with the highest incidence in the 47-57 year age group. Hypertension was the most common comorbid condition (30%), followed by peptic ulcer disease (20%). Ribavirin was the main stay of treatment used. The analysis showed no significant relationship between comorbidities and mortality, as the majority of cases (85%) had outstanding outcomes. However, there was a significant relationship (p=0.04) between the level of education and outcomes, with most individuals having a tertiary education and experiencing positive outcomes. \u0000Conclusion: According to this study, it was discovered that there were no significant relationship between co morbidities and mortality as majority of the cases reviewed were seen to have good outcomes with the aid of the current treatment (ribavirin).","PeriodicalId":506708,"journal":{"name":"Journal of Advances in Medicine and Medical Research","volume":"22 3","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-07-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141646609","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
N. M. Harry, Kenechukwu Anona, Vivien O Obitulata-Ugwu, Olubukola Anike Kuye, Oluwatosin Arubuolawe, I. Folorunsho, A. K. Busari, Chidalu N Ibeneme, Amarachukwu Diala, Victory Afolabi, Gibson Anugwom
{"title":"Potential Role of Glucagon-like Peptide-1 (GLP-1) Receptor Agonist in the Treatment of Bulimia Nervosa","authors":"N. M. Harry, Kenechukwu Anona, Vivien O Obitulata-Ugwu, Olubukola Anike Kuye, Oluwatosin Arubuolawe, I. Folorunsho, A. K. Busari, Chidalu N Ibeneme, Amarachukwu Diala, Victory Afolabi, Gibson Anugwom","doi":"10.9734/jammr/2024/v36i75514","DOIUrl":"https://doi.org/10.9734/jammr/2024/v36i75514","url":null,"abstract":"Background: Bulimia nervosa (BN) is a severe eating disorder characterized by recurrent episodes of binge eating followed by compensatory behaviors such as self-induced vomiting, misuse of laxatives, fasting, or excessive exercise. Current treatment strategies, including cognitive-behavioral therapy (CBT) and pharmacotherapy, have limitations, with many patients not responding adequately and experiencing high relapse rates. GLP-1 receptor agonists, initially developed for type 2 diabetes mellitus (T2DM) and chronic weight management, have shown potential in regulating appetite and modifying behavior, suggesting a possible role in treating BN. \u0000Objective: This review aims to assess the current evidence regarding the efficacy and safety of GLP-1 receptor agonists, particularly Semaglutide, in the treatment of bulimia nervosa. \u0000Methods: A comprehensive literature search was conducted using PubMed and Google Scholar, focusing on articles published between 2014 and 2024. Studies included were clinical trials, case reports, and reviews addressing the use of GLP-1 receptor agonists in BN. The search terms included \"Bulimia Nervosa,\" \"Semaglutide,\" \"GLP-1 receptor agonists,\" and related terms. After screening and removing duplicates, five relevant articles were included in the qualitative synthesis. \u0000Results: The included studies demonstrated that GLP-1 receptor agonists, such as Semaglutide, liraglutide, and dulaglutide, effectively reduced binge eating episodes and body weight in patients with BN. In a notable case report, a patient with long-standing BN experienced complete resolution of symptoms within two weeks of starting liraglutide, sustained over five years. Retrospective cohort and open-label studies also showed significant reductions in binge eating severity with GLP-1 receptor agonists compared to other anti-obesity medications. Additionally, preclinical studies suggested these agents' potential in modulating appetite and reward pathways in the brain. \u0000Conclusion: The evidence indicates that GLP-1 receptor agonists may be a promising alternative pharmacotherapy for bulimia nervosa, addressing both appetite regulation and behavioral aspects of the disorder. However, the current paucity of large-scale, randomized controlled trials necessitates further research to confirm these findings and establish the efficacy, safety, and optimal dosing of GLP-1 receptor agonists in the treatment of BN. The favorable psychiatric side effect profile and potential for improved patient adherence highlight the need for continued exploration of these agents in clinical practice.","PeriodicalId":506708,"journal":{"name":"Journal of Advances in Medicine and Medical Research","volume":"47 3","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-07-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141652218","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Diagnostic Value of Fiberoptic Bronchoscopy in Non-resolving Pneumonia: Case Series and Implications","authors":"Rushita D. Nakarani, R.K. Chopra","doi":"10.9734/jammr/2024/v36i75513","DOIUrl":"https://doi.org/10.9734/jammr/2024/v36i75513","url":null,"abstract":"Non-resolving or slowly resolving pneumonia presents a significant diagnostic challenge, characterized by persistent radiographic abnormalities despite appropriate antibiotic therapy. This study explores the pivotal role of Fiberoptic Bronchoscopy (FOB) in diagnosing and managing non-resolving pneumonia. Through detailed case presentations, the study illustrates how FOB facilitates precise sampling and identification of underlying causes such as malignancies, infections, and other pulmonary conditions. FOB's ability to provide cytological, microbiological, and pathological insights proves essential in guiding targeted treatment strategies, ultimately improving patient outcomes. The cases discussed underscore the importance of FOB in resolving diagnostic uncertainties, particularly in complex clinical scenarios where standard treatments fail.","PeriodicalId":506708,"journal":{"name":"Journal of Advances in Medicine and Medical Research","volume":"44 11","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-07-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141652362","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Gender-based Violence (GBV) on Bangladeshi Women and Girls during COVID-19 in Toronto: Forms, Causes, and Mental Health Impacts","authors":"Q. S. Islam, Nasima Akter","doi":"10.9734/jammr/2024/v36i75505","DOIUrl":"https://doi.org/10.9734/jammr/2024/v36i75505","url":null,"abstract":"Aims: The COVID-19 pandemic lockdown has led to a rise in the number of gender-based violence (GBV) cases within families. This increase is mainly due to patriarchal influence, prolonged stay at home, social isolation, and financial abuse. Women and girls, in particular, have been adversely affected by this phenomenon, experiencing significant mental health impacts. A study conducted in Toronto explored the various types and causes of violence against South Asian Bangladeshi women and girls and how it affects their mental health, too. \u0000Methodology: Bangladeshi-Canadian Community Services (BCS), an ethnic organization conducted a study on gender-based violence (GBV) from Sep to Dec 2021. Two extensive Zoom group discussions involved 55 females and six males, including social workers (n=9), community leaders/workers (n=17), community youth ambassadors (n=9), and community members (n=26, among them n=11 were victims). Audio recordings were transcribed and translated into English, then thematically coded to identify forms of GBV and provide narratives based on participants' experiences. \u0000Results: South Asian Bangladeshi women and girls have been subjected to various forms of violence by their husbands or male family members, such as physical, psychological/emotional, verbal, and financial violence. Physical violence includes shaking their wives' hands and necks and pushing wives and girls. Psychological, verbal, and financial violence includes scolding, threatening, demoralizing, blaming, belittling, coercing, stealing money, and committing financial fraud. The causes of violence against women during the lockdown are related to the loss of husbands' jobs and idleness, the tendency to establish male power over women out of fear of losing patriarchal control during a crisis, husbands' mental turmoil due to the lockdown and financial crisis, women's protest against extramarital relationships, fear of contracting viruses, taking advantage of women's vulnerability, and greediness towards wives' money. As a result of this violence, many victims have reported experiencing anxiety, mental trauma, frustration, distress, depression, and discrimination. Victims of violence have faced many obstacles in accessing appropriate providers, such as language barriers and threats from their husbands. \u0000Conclusions: The COVID-19 pandemic has disproportionately affected South Asian Bangladeshi women and girls who are experiencing gender-based violence. To address this issue, policymakers, governments, and ethnic organizations must collaborate to create comprehensive plans that aim to eliminate gender-based violence, as well as associated cultural problems and stigma. Community organizations can provide resources and support for victims, working with families and husbands to create a safer environment for those affected.","PeriodicalId":506708,"journal":{"name":"Journal of Advances in Medicine and Medical Research","volume":"124 10","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-07-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141665389","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}